| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/11/2008 | US20080306043 Sabcomeline Alone or Combined with a Mood Stabilising or Antimanic Agent to Treat Bipolar Disorders |
| 12/11/2008 | US20080306042 Triazole Derivatives |
| 12/11/2008 | US20080306041 Cardiovascular Compounds Comprising Heterocyclic Nitric Oxide Donor Groups, Compositions and Methods of Use |
| 12/11/2008 | US20080306040 Antibacterial amide macrocycles VII |
| 12/11/2008 | US20080306039 Loteprednol Etabonate Aqueous Suspension |
| 12/11/2008 | US20080306038 Compositions and Methods for Modulating Inflammation Using Fluoroquinolones |
| 12/11/2008 | US20080306037 Product for Use in the Prevention and Treatment of Cardiovascular Diseases, Cancer and Chronic Inflammatory Diseases |
| 12/11/2008 | US20080306036 Triphenylethylene Compounds Useful as Selective Estrogen Modulators |
| 12/11/2008 | US20080306035 Methods and Compositions for Treating Female Infertility Using Clomiphene |
| 12/11/2008 | US20080306034 Method of Administering a Therapeutic |
| 12/11/2008 | US20080306033 Use of Non-Steroidal Anti-Inflammatory Drugs by Inhalation in the Treatment of Acute and Chronic Bronchitis |
| 12/11/2008 | US20080306032 7-Phenyl-Substituted Tetracycline Compounds |
| 12/11/2008 | US20080306031 Methods of Inhibiting Poxvirus Growth |
| 12/11/2008 | US20080306030 Use of a TRPM5 Inhibitor to Regulate Insulin and GLP-1 Release |
| 12/11/2008 | US20080306029 Prevention, Treatment, and Amelioration of Radiation Induced Enteritis |
| 12/11/2008 | US20080306028 Erianin Salts, Their Preparation Methods and Pharmaceutical Compositions Containing the Same |
| 12/11/2008 | US20080306027 Fluoroalkoxycombretastatin Derivatives, Method For Producing the Same and Use Thereof |
| 12/11/2008 | US20080306025 N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use |
| 12/11/2008 | US20080306024 Method for micro-incision cataract surgery, a method of evaluation of a viscoelastic material , a composition for evaluation of a viscoelastic material and a method for evaluation using the composition |
| 12/11/2008 | US20080306023 Derivatives of Hyaluronic Acid, Their Preparation Process and Their Uses |
| 12/11/2008 | US20080306022 Agent for Applying to Mucosa and Method for the Production Thereof |
| 12/11/2008 | US20080306020 Skin-Protecting Alkalinity-Controlling Composition and the Use Thereof |
| 12/11/2008 | US20080306019 Dopamine Receptor Agonists in the Treatment and Prevention of Hiv-Induced Dementia |
| 12/11/2008 | US20080306018 Micro-Rna Expression Abnormalities of Pancreatic, Endocrine and Acinar Tumors |
| 12/11/2008 | US20080306017 Microrna-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Lung Cancer |
| 12/11/2008 | US20080306016 Nucleic Acid Functionalized Nanoparticles for Therapeutic Applications |
| 12/11/2008 | US20080306015 Using RNA interference to treat and prevent diabetes, alzheimer's, cancer disorders; antisense agents |
| 12/11/2008 | US20080306014 Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial |
| 12/11/2008 | US20080306013 Illudin analogs useful as antitumor agents |
| 12/11/2008 | US20080306012 Polysaccharide-Derived Nitric Oxide-Releasing Carbon-Bound Diazeniumdiolates |
| 12/11/2008 | US20080306011 Method of Controlling the Proliferation of Vascular Endothelial Cells and Inhibiting Lumen Formation |
| 12/11/2008 | US20080306004 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 12/11/2008 | US20080305994 Pharmaceutical Compositions and Method for Treating, Reducing, Ameliorating, Alleviating, or Preventing Dry Eye |
| 12/11/2008 | US20080305989 Peptides faciliatate non-invasive percutaneous or transdermal drug delivery of insulin, growth hormone, apomorphine, or PT-141 (peptide analogue of alpha -melanocyte-stimulating hormone) |
| 12/11/2008 | US20080305987 Sex-specific regulation of aging and apoptosis |
| 12/11/2008 | US20080305508 Methods of screening for compounds that modulate TAFIa activity, compounds, and methods of using the compounds |
| 12/11/2008 | US20080305194 Extracts of passion fruit and uses thereof |
| 12/11/2008 | US20080305193 Cosmetic compositions |
| 12/11/2008 | US20080305186 Method and Composition for the Treatment of Cardiac Hypertrophy |
| 12/11/2008 | US20080305181 Compositions and Methods for Treatment of Vascular Grafts |
| 12/11/2008 | US20080305177 Method of administering testosterone |
| 12/11/2008 | US20080305176 Process For Loading Polymer Particles With Drug |
| 12/11/2008 | US20080305173 Amorphous drug beads |
| 12/11/2008 | US20080305172 Ophthalmic depot formulations for periocular or suconjunctival administration |
| 12/11/2008 | US20080305171 Pyrrolopyrazine, formulations, methods of manufacture, and methods of use there |
| 12/11/2008 | US20080305169 Pharmaceutical Compositions Comprising Nitrogen-Containing Fused Ring Coumpounds |
| 12/11/2008 | US20080305167 Tamper-resistant oral opioid agonist formulations |
| 12/11/2008 | US20080305165 Sustained release oral formulation and process for the preparation thereof |
| 12/11/2008 | US20080305164 Crystalline composition containing escitalopram |
| 12/11/2008 | US20080305163 Butylphthalide soft gel capsule and its preparation procedure |
| 12/11/2008 | US20080305162 Incontinence Treatment Methods |
| 12/11/2008 | US20080305161 Injectable depot formulations and methods for providing sustained release of nanoparticle compositions |
| 12/11/2008 | US20080305160 Oral Medicament For The Modified Release Of At Least One Active Principle, In Multimicrocapsule Form |
| 12/11/2008 | US20080305159 Ibuprofen-Hydrocodone-Antihistamine Composition |
| 12/11/2008 | US20080305158 Methods For the Preparation of Stable Pharmaceutical Solid Dosage Forms of Atorvastatin and Amlodipine |
| 12/11/2008 | US20080305155 Transdermal Systems Containing Multilayer Adhesive Matrices to Modify Drug Delivery |
| 12/11/2008 | US20080305150 Polymer Composition And Dosage Forms Comprising The Same |
| 12/11/2008 | US20080305142 Cell Free Biosynthesis of High-Quality Nucleic Acid and Uses Thereof |
| 12/11/2008 | US20080305140 Long-Term Delivery Formulations and Methods of Use Thereof |
| 12/11/2008 | US20080305139 Pharmaceutical Compositions Comprising Dextran with a Molecular Weight of 1.0-100 Kda and Processes for Their Preparation |
| 12/11/2008 | US20080305132 Cosmetic Patch for Skin Treatment |
| 12/11/2008 | US20080305118 Treatment Of Type 1 Diabetes With Inhibitors Of Macrophage Migration Inhibitory Factor |
| 12/11/2008 | US20080305115 Reduced-mass, long-acting dosage forms |
| 12/11/2008 | US20080305110 Novel Ligand of G Protein Coupled Receptor Protein and Use Thereof |
| 12/11/2008 | US20080305107 Targeting slow-growing, relatively mutationally spared cancer stem line; early cancer treatment and reduce the likelihood of clinical relapse |
| 12/11/2008 | US20080305102 Therapeutic Agent for Cancer Comprising Substance Capable of Inhibiting Expression or Function of Synoviolin as Active Ingredient and Screening Method for the Therapeutic Agent for Cancer |
| 12/11/2008 | US20080305099 degrades soluble and insoluble A beta so that it can prevent the accumulation of A beta in brain or reduce the accumulation; Alzheimer's disease and Down's syndrome |
| 12/11/2008 | US20080305096 Method and composition for providing controlled delivery of biologically active substances |
| 12/11/2008 | US20080305095 Nutritional Drink |
| 12/11/2008 | US20080305094 Nutritional Composition for Improving Skin Condition and Preventing Skin Diseases |
| 12/11/2008 | US20080305090 increase a person immunity by oral administering a mixture including a dextran, promoting the cell growth and colonizing in the intestine of a subject without supplying L. casei subsp. casei at all times |
| 12/11/2008 | US20080305088 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
| 12/11/2008 | US20080305083 Gfap-based gene therapy for treatment of retinal diseases |
| 12/11/2008 | US20080305082 1,4-Bis-N-Oxide-5,8- Dihydroxyanthracenedione Compounds and the Use Thereof |
| 12/11/2008 | US20080305081 Novel aminopyrimidine derivatives as PLK1 inhibitors |
| 12/11/2008 | US20080305077 Pharmaceutical compositions and methods for enhancing targeting of therapeutic compounds to the central nervous system |
| 12/11/2008 | US20080305076 Method of inducing memory b cell development and terminal differentiation |
| 12/11/2008 | US20080305075 Treatment of Hyperproliferative Diseases with Vinca Alkaloid N-Oxide and Analogs |
| 12/11/2008 | US20080305073 Therapeutic Agents for the Treatment of Hmgb1-Related Pathologies |
| 12/11/2008 | US20080305070 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 12/11/2008 | US20080305069 Cosmetic Use of Tensing Agents to Improve the Thickness of the Skin and/or the Radiance of the Complexion |
| 12/11/2008 | US20080305068 Cosmetic compositions having improved transfer resistance |
| 12/11/2008 | US20080305066 2-C-Substituted Propane-1,3-Dicarbonyl Compounds and Their Use in Neutralising Malodour |
| 12/11/2008 | US20080305055 Anti-Radical Agents |
| 12/11/2008 | US20080305051 Menthane Carboxamide Derivatives Having Cooling Properties |
| 12/11/2008 | US20080305050 Analysis of P. aeruginosa infection in patients |
| 12/11/2008 | US20080305039 Facilitated Transport of Bisphosphonates by Vitamin C |
| 12/11/2008 | US20080305038 Transport of Nano-and Macromolecular Structures Into Cytoplasm and Nucleus of Cells |
| 12/11/2008 | DE10322108B4 Antiandrogene Pyrrolidine mit tumorhemmender Wirksamkeit Antiandrogens pyrrolidines with antitumor efficacy |
| 12/11/2008 | DE102007026713A1 New 5-keto-D-fructose useful as medicaments, foodstuff e.g. marmalade, pasta, chocolate or sauces, sweetener, and for preparing products that are useful in the therapy of adiposity or diabetes |
| 12/11/2008 | DE102007026341A1 Benzoxazolonderivate Benzoxazolonderivate |
| 12/11/2008 | DE102007025717A1 Arylether-pyridazinonderivate Aryl ether pyridazinone derivatives |
| 12/11/2008 | DE102005015128B4 Wafer enthaltend Steroidhormone Wafer containing steroid hormones |
| 12/11/2008 | CA2727100A1 Treatment of neurofibromatosis with radicicol and its derivatives |
| 12/11/2008 | CA2726848A1 Hydroxyproline compositions and uses thereof |
| 12/11/2008 | CA2725953A1 Methods for production and uses of multipotent cell populations, pluripotent cell populations, neuronal cell populations, and muscle cell populations |
| 12/11/2008 | CA2698704A1 Novel compounds |
| 12/11/2008 | CA2697959A1 Pharmaceutical composition comprising a substrate and a coating containing an active ingredient and polyvinylalcohol |
| 12/11/2008 | CA2693694A1 Mixed lineage kinases and metabolic disorders |
| 12/11/2008 | CA2693552A1 Pyridone compound |